CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th.
Management will participate in 1×1 meetings on Wednesday, February 14th. There will be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.
CONTACT: Investor Inquiries: ICR Westwicke Mike Piccinino, CFA OrganoIR@westwicke.com Press and Media Inquiries: Organogenesis communications@organo.com
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF)…
– AI-driven speech to text wearable transcription enhances accessibility for the deaf or hard of…
SAN FRANCISCO, June 30, 2025 /PRNewswire/ -- In a powerful demonstration of public safety innovation and…
Strategic hire strengthens Siemens' leadership in industrial AIReporting to Peter Koerte, Member of the Managing…
CLEARWATER, Fla., June 30, 2025 /PRNewswire/ -- BayCare has named Patrick Brown, MD, FAAP, as…
LOS ANGELES, June 30, 2025 /PRNewswire/ -- Ceretone, a pioneering force in affordable hearing technology, today…